| ARE | antioxidant response element |
| α1-AR | α1- adrenoceptor |
| β -AR | β-adrenoceptor |
| BDNF | brain-derived neurotrophic factor |
| BPH | benign prostatic hyperplasia |
| CAT | catalases |
| COX-2 | cyclooxygenase-2 |
| CRP | C-reactive protein |
| DO | detrusor overactivity |
| EGCG | epigallocatechin-3-gallate |
| F2-IsoPs | F2-isoprostanes |
| GSH | glutathione |
| GSH-Px | glutathione peroxidase |
| HFHS | high fat high sugar |
| HO-1 | hemeoxygenase-1 |
| IC/PBS | interstitial cystitis/painful bladder syndrome |
| I/R | ischemia/reperfusion |
| Keap1 | Kelch-like ECH-associated protein 1 |
| LUTS | lower urinary tract symptoms |
| MDA | malondialdehyde |
| NGF | nerve growth factor |
| Nrf2 | nuclear transcription factor E2-related factor 2 |
| NOS | nitric oxide synthase |
| NOX | nicotinamide adenine dinucleotide phosphate (NADPH) oxidase |
| OAB | overactive bladder |
| OVX | ovariectomy |
| OHD | ovarian hormone depletion (deficiency) |
| 8-OHdG | 8-hydroxy-2′-deoxyguanosine |
| PBOO | partial bladder outlet obstruction |
| PGE2 | prostaglandin E2 |
| ROS | reactive oxygen species |
| SOD | superoxide dismutase |
| UTI | urinary tract infection |